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Abstract 
8-Hydroxyqunoline derivatives were synthesised by 
treating 5-chloromethyl-8-hydroxy quinoline with 
imidazole and characterized using NMR and mass 
spectrometry. 2-mercaptoimidazole derivatives of 8-
hydroxy quinoline were also synthesized and 
characterized. One of the compounds in this series has 
been tested for dengue activity along with other series of 
compounds, but did not show any activity against dengue 
virus. 
Keywords: Dengue virus, 8-hydroxy quinoline, imidazole, 2-
mercaptoimidazole 
1. Introduction 
Dengue fever is estimated by WHO to cause 50-100 million 
infections yearly with ~22,000 deaths, mostly among children1. 
Dengue virus (DENV) is responsible for an acute febrile illness, 
with occasional serious complications from thrombocytopenia and 
plasma leakage that leads to pleural effusion, and hypovolemic 
shock2. 
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In a previous study, high throughput screening (HTS) using West 
Nile Virus (WNV) protease as the target and identified inhibitors 
with chemically diverse scaffolds has been performed. One group 
of compounds has the 8-hydroxyquinolines (8-HQ) as the chemical 
scaffold with different substituents of 8-HQ ring (7-position). Based 
upon initial findings some 8-Hydroxy quinoline derivatives have 
been found to have antidengueactivities3,4. These series of 
compounds were mannich bases of 8-hydroxy quinolone with 
different amines. This prompted us to replace amines with 
imidazole and 2-mercapto imidazole, synthesize the compounds 
and study their biological activity. 
The present study deals with the synthesis and characterization of 
quinoline bound imdiazoles and study of the anti-dengue property. 
2. Experimental methods 
2.1 Chemicals and apparatus 
8-Hydroxyquinoline, 5-chloro-8-hydroxyquinoline and 
paraformaldehyde were obtained from S.D.Fine chemicals (LR 
grade). Imidazole was obtained from Chem-labs Ltd. 
India.Isopropyl-1-thio-β-D-galactopyranoside was obtained from 
Sigma Aldrich Ltd. The fluorogenic tetra-peptide substrates, Bz-
Nle-Lys-Arg-Arg-AMC was custom synthesized by NeoBioScience 
(Cambridge, MA). AMC was procured from Anaspec, Inc 
(Fremont, CA).  
The melting points of the compounds were recorded on BUCHI 
melting point instrument B-540. 1H NMR spectra were recorded (in 
DMSO-d6/CDCl3) on A 400MHz NMR spectrometer. A BUCHI B-
540 spectrometer was used to record mass spectra. Thin layer 
chromatography (TLC) was used to monitor the progress of the 
reactions and purity of the products. Appropriate solvent systems 
were used as eluents. 
Procedure for the synthesis of 5-(1H-imidazol-1-
ylmethyl)quinolin-8-ol hydrochloride (5) 
To a solution of 5-(chloromethyl) quinolin-8-ol hydrochloride (4) 
(0.021mole) in 50ml of N,N- dimethylformamide (DMF) was added 
imidazole (1) (0.043mole) under stirring. The mixture was heated to 
90-95°C for 6 hours. The solvent is distilled off completely. The 
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obtained residue is treated with chloroform and heated to 60°for 
30minutes. The product 5-(1H-imidazol-1-ylmethyl)quinolin-8-ol 
hydrochloride (5) was filtered and dried in the oven at 70-75°C for 
4 hours, m.p. 262-264 °C. 
Procedure for the synthesis of7-[(1H-imidazol-2-
ylsulfanyl)methyl]quinolin-8-ol (7) 
To a solution of8-hydroxy quinoline (2) (0.015mol) in 25ml of 
methanol was added paraformaldehyde (0.015mol) and 2-
mercaptoimidazole (0.015mol) under stirring. The mixture is 
heated to 50-55° for 6 hours. The solvent is distilled off                                                              
completely. To the residue obtained added diethylether. The 
precipitated product7-[(1H-imidazol-2-ylsulfanyl)methyl]quinolin-
8-ol (7) was filtered and dried at 70-75ºC for 4hrs, m.p. 218-220°C. 
Procedure for the synthesis of5-(chloromethyl) quinolin-8-ol 
hydrochloride (4): 
A mixture of 8-hydroxyquinoline (0.05mol), 8ml. of concentrated 
hydrochloric acid and 37% formaldehyde (0.05mol) was treated 
with hydrogen chloride gas for 90min. The product was filtered 
and dried to get 5-(chloromethyl) quinolin-8-ol hydrochloride (4), 



















































































2.2 Preparation of samples for biological studies 
The DENV2 NS2BH-NS3pro expression plasmid encoding the 
protease precursor used in this study contains the hydrophilic 
domain of NS2B cofactor (45 amino acids) and the N terminal NS3 
protease domain (185 amino acids) separated by the two naturally 
occurring amino acids, QR, at the P2 and P1 positions, respectively 
at the N-terminus of the DENV2 NS2B-NS3pro cleavage site. The 
construction of the expression plasmid encoding the DENV2 NS2B-
QR-NS3pro in pQE30 vector (Qiagen) has been described 
previously7. The expression and purification of the DENV2 NS2B-
QR-NS3pro were achieved as follows. E. coli Top 10 F’ cells 
(Invitrogen, Carlsbad, CA) were transformed with the plasmid 
pQE30 DENV2 NS2B-NS3. Bacterial growth was monitored at 37º C 
upto an optical density of0.6 at 600 nm. Isopropyl-1-thio-β-D-
galactopyranoside (1mM) induced cells were incubated at 16º C for 
20 hours. Cells were separated by centrifugation (5000 x g) for 15 
min at 4º C, washed with 50 mMTris-HCl (pH 7.5) and 200 mMNaCl 
buffer solution, centrifuged (5000 x g) for 15 min at 4º C. The pellet 
was re-suspended with 50 mM HEPES (pH7.0), 500 mMNaCl, 0.5% 
Triton X-100, and 0.05 mg/ml lysozyme; then, incubated 30 min on 
ice. Cells were disrupted by sonication (pulse 15 seconds in 1 min) 
for 20 min, and centrifuged (15000 x g; 30min;4º C). Centrifugate 
was collected and incubated for 1 h at 4°C with Talon resin (BD 
Bioscience, San Jose, CA), which was pre-equilibrated in 50 mM 
HEPES (pH7.0), 500 mMNaCl (buffer A). The affinity resin was 
centrifuged at 400 x g for 10 min at 4º C, washed with buffer A and 
packed into the column. The column was washed with 15 ml of 10 
mM imidazole in buffer A, and eluted with 500 mM imidazole in 
buffer A. The concentrated fractions were determined by Bradford 
Reagent (Thermo Scientific), pooled, and dialyzed against 1 liter of 
50 mMTris-HCl, pH 7.5, 300 mMNaCl, and 40% Glycerol. The 
aliquots were stored at ─80º C until use. The compounds were 
dissolved in dimethylsulfoxide (DMSO) to yield 25 mM stocks, and 
stored at -20º C.  
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3. Results and Discussion 
Imidazole (1) is reacted with 8-hydroxyqinoline (2) and 
paraformaldehyde under different conditions. This reaction did not 
give the expected product 7-(1H-imidazol-1-ylmethyl) quinolin-8-ol 
(3). Further 8-hydroxyquinoline (2) is reacted with 
paraformaldehyde in aqueous hydrochloric acid as reported in 
litrature5 to get 5-(chloromethyl)quinolin-8-ol hydrochloride (4). 
This was reacted with imidazole to give 5-(1H-imidazol-1-
ylmethyl) quinolin-8-ol hydrochloride (5). Compound (5) has been 
screened for anti-dengue activity. 2-Mercptoimidazole (6) was 
reacted with 8-hydroxyqinoline (2) and paraformaldehyde to get7-
[(1H-imidazol-2-ylsulfanyl) methyl]quinolin-8-ol (7). The same 
reaction has been repeated with 5-chloro-8-hydroxyquinoline (8)to 
afford 5-chloro-7-[(1H-imidazol-2-ylsulfanyl)methyl]quinolin-8-ol 
(9), scheme 1. 2-Mercaptoimidazole (6) required for the work is 
prepared according to the reported procedure6.  
The newly synthesized compounds were characterised by using1H 
NMR and mass spectral data and the spectral details of selected 
compounds are given below (4, 5 and 7) 
5-(1H-imidazol-1-ylmethyl) quinolin-8-ol hydrochloride (5): Pale 
yellow crystalline solid; Yield(78%); Melting point:262-264°C. 1H 
NMR(400MHz, DMSO-d6) δH(ppm):  9.93 (s, hydroxyl O-H, 1H), 
8.86(m, quinoline, 1H), 8.54(m, quinoline, 1H), 7.75(s, imidazole, 
1H), 7.60(q, J=4.12Hz, quinoline, 1H), 7.36(d, J=7.88Hz, quinoline, 
1H),7.10(t, J=0.96Hz, imidazole-H, 1H), 7.05(d, J=7.84Hz, quinoline, 
1H), 6.85(s, imidazole-H, 1H), 5.56(s, CH2, 2H); (m+1)+ 226. 
7-[(1H-imidazol-2-ylsulfanyl)methyl]quinolin-8-ol (7): Yellow 
crystalline solid; Yield(82%); Melting point:218-220°C. 1H 
NMR(400MHz, DMSO-d6) δH(ppm): 12.20(s, Imidaole N-H, 1H), 
9.94(s, hydroxyl O-H, 1H), 8.86(m,quinoline, 1H), 8.69(m,  
quinoline, 1H), 7.58(q, J=4.12Hz, quinoline, 1H), 7.44(d, J=7.84Hz, 
quinoline, 1H), 7.06(d, J=7.84Hz, quinoline, 1H), 6.84(m,imidazole-
H, 1H), 6.78(m,  imidazole-H, 1H), 5.47(s, CH2, 2H); (m+1)+258. 
5-(chloromethyl)quinolin-8-ol hydrochloride (4):Yellow solid; 
Yield(82%); Melting point:283°C(dec). 1H NMR(400MHz, DMSO-




d6) δH(ppm): 9.08(m, quinoline, 2H),  8.02(q,  quinoline, 1H),  
7.69(d, quinoline, 1H),  7.50(d, quinoline, 1H),  4.15(s, CH2, 2H). 
3.1 Biological Activity 
In this study, the efficacy of compound (5) along with a number of 
8-HQ derivatives with different substitutions at the 7-position of 
the 8-HQ ring by using an in vitro protease assay has been 
evaluated. Among which one of the compound inhibited the viral 
protease in vitro as well as DENV2 replication in mammalian cells 
expressing the DENV2 Renilla luciferase (Rluc) reporter replicon. 
We describe here the construction and characterization of the 
DENV2 Rluc reporter replicon expressing baby hamster kidney 
(DENV2-Rluc-BHK21Rep) cell line.Results are presented in Table 1 






















Three quinoline bound imdiazoles were synthesized and 
characterized by1H NMR and mass spectral data successfully. 
Among synthesized compounds one compound (5) has been 
screened for antidengue property.  It did not show activity against 
dengue virus. 
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